Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of indomethacin in in the prevention of premature ovulation in in vitro fertilisation treatment in a with a GnRH-antagonist modified natural cycle.

Trial Profile

Efficacy of indomethacin in in the prevention of premature ovulation in in vitro fertilisation treatment in a with a GnRH-antagonist modified natural cycle.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2011

At a glance

  • Drugs Indometacin (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
    • 02 May 2009 Additional lead trial centre University Medical Center Groningen, Department of Obstetrics and Gynaecology reported by Netherlands Trial Register.
    • 09 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top